What people are saying - Write a review
We haven't found any reviews in the usual places.
The Response to Health Care
Issue 4 1995
30 other sections not shown
Other editions - View all
1976 Amendments accompanying text advertising agency agency's Antitrust application approval Bendectin bill carcinogenic Circuit clinical codified at 21 competition Cong Congress congressional costs court Daubert Daubert standard decision Delaney Clause dietary fiber dietary supplements drug information effects expert F-D-C Rep FDA's FDCA Federal final regulations Food Additives Food and Drug food labels formulary Frye Genentech hammered final rules health claims HMOs ibuprofen industry issue managed care organizations mandatory PPI marketing exclusivity medical devices ment NLEA nutrition labeling Orphan Diseases Orphan Drug Act Patient Package Inserts PBMs pesticides pharmaceutical companies pharmaceutical manufacturers physicians Pink Sheet plaintiffs potential PPI program prescription drug promulgated proposed regulations proposed rules regulatory result risk rulemaking safety scientific evidence sponsor standard Stat statutory deadlines studies Supp supra note testimony therapeutic tion